Article
Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
BMC infectious diseases - 10 May 2022
Climaco-Arvizu Samantha, Flores-López Víctor, González-Torres Carolina, Gaytán-Cervantes Francisco Javier, Hernández-García María Concepción, Zárate-Segura Paola Berenice, Chávez-Torres Monserrat, Tesoro-Cruz Emiliano, Pinto-Cardoso Sandra María, Bekker-Méndez Vilma Carolina
Abstract excerpt
INTRODUCTION: In Mexico, HIV genotyping is performed in people living with HIV (PLWH) failing their first-line antiretroviral (ARV) regimen; it is not routinely done for all treatment-naive PLWH before ARV initiation. The first nationally representative survey published in 2016 reported that the prevalence of pretreatment drug mutations in treatment-naive Mexican PLWH was 15.5% to any antiretroviral drug and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.